Efficacy of cabozantinib (C) vs everolimus (E) in patients (pts) with advanced renal cell carcinoma (RCC) and bone metastases (mets) from the phase III METEOR study.
Year: 2016
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Institut Gustave Roussy, Queen Mary University of London, Barts Cancer Institute, Memorial Sloan Kettering Cancer Center, The Ohio State University Wexner Medical Center, Hôpital Européen Georges-Pompidou, Tumour Institute of Tuscany, Hospital Universitario 12 De Octubre, University of Pittsburgh Medical Center, Medical University of South Carolina, University of Iowa Hospitals and Clinics, University of Iowa Health Care, University of Iowa Holden Comprehensive Cancer Center, Exelixis (United States), Dana-Farber Brigham Cancer Center
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2525950252